Pingnan Xiao Selected Research

Pingnan Xiao Research Topics

3	Neoplasms (Cancer) 04/2024 - 01/2018
3	Leukemia 04/2024 - 01/2023
2	Infections 04/2024 - 01/2023
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 01/2017
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2012
1	Hematologic Neoplasms (Hematological Malignancy) 04/2024
1	Disease Progression 04/2024
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2023
1	Cytokine Release Syndrome 01/2023
1	Cytopenia 01/2023
1	Residual Neoplasm 01/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Juvenile Myelomonocytic Leukemia 01/2018
1	Asthma (Bronchial Asthma) 01/2017

2	Chimeric Antigen ReceptorsIBA 04/2024 - 01/2023
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2017
1	MethyltransferasesIBA 04/2024
1	Proteins (Proteins, Gene)FDA Link 04/2024
1	Lysine (L-Lysine)FDA Link 04/2024
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	Laminin (Merosin)IBA 01/2022
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 01/2018
1	LeukotrienesIBA 01/2017
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2017
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 01/2017
1	Oncogene Proteins (Oncogene Protein)IBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2012

2	Hematopoietic Stem Cell Transplantation 04/2024 - 01/2023
2	Drug Therapy (Chemotherapy) 04/2024 - 01/2023
2	Therapeutics 04/2024 - 01/2023
1	Aftercare (After-Treatment) 01/2023